Anorectal Microbicide Project(AMP): Rectal Health, Behaviors and Microbicide Acceptability
NCT ID: NCT00377221
Last Updated: 2021-08-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
896 participants
OBSERVATIONAL
2006-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Human Intestinal Microbiome and Surgical Outcomes in Patients Undergoing Colorectal Cancer Surgery
NCT04005118
Combining Risk Factors and Faecal Immunochemical Testing in Colorectal Cancer Screening: a Randomized Controlled Trial
NCT04490551
Time Longitudinal Study of the Microbiome in Colorectal Cancer Subjects
NCT03951792
Exploratory Study of Rectal Mucus for Diagnosing Disease
NCT04659590
Endomicrocancer: Confocal Endomicroscopy in Patients With High Risk of Colorectal Cancer
NCT01052376
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. At least 18 years of age
2. Willing to be tested for STIs including HIV
3. Willing to undergo an anal exam
4. Mentally competent to understand study procedures and give informed consent.
5. For the NO-RAI groups:
No RAI in the past year for the non-RAI men and women
6. For the practicing RAI groups:
Males: report RAI in the past 30 days Females: report RAI in the past 12 months
Exclusion Criteria
2. Unwilling to be tested for STIs (and HIV)
3. Unwilling to undergo an anal exam
4. Unwilling to complete study questionnaire
5. Not mentally competent to understand study procedures and give informed consent.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, Los Angeles
OTHER
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
AIDS Research Alliance
OTHER
Johns Hopkins Bloomberg School of Public Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pamina Gorbach, DrPH
Role: PRINCIPAL_INVESTIGATOR
University of California, Los Angeles
Peter A Anton, MD
Role: PRINCIPAL_INVESTIGATOR
University of California, Los Angeles
Ross Cranston, MD
Role: PRINCIPAL_INVESTIGATOR
University of California, Los Angeles
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AIDS Research Alliance
Los Angeles, California, United States
Johns Hopkins University
Baltimore, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
05-07-098
Identifier Type: -
Identifier Source: secondary_id
H.34.05.08.24
Identifier Type: -
Identifier Source: secondary_id
ARA010
Identifier Type: -
Identifier Source: secondary_id
U19-AI060614:P3 Aim1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.